Global Microarray Market to Catapult to $7.4 Billion by 2018
(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 08/12/13 -- TriMarkPublications.com cites in its newly published " Markets" report that the global market will catapult to $7.4 billion by 2018. For more information, visit: .
can be categorized into five main modalities: DNA, protein, tissue, low complexity and carbohydrate. The largest contributor to the market is the DNA segment, which is projected to grow at a compound annual growth rate (CAGR) of over 15%. North America is the largest regional market with 40% of the market, followed by Europe, which has 25% of the market, and Asia, which has 18% of the market.
The " Markets" report covers:
DNA
Protein
Tissue
Low Complexity
Carbohydrate
Forward Phase
Reverse Phase
Peptoid Arrays
Nucleic Acid Programmable Protein Arrays (NAPPA)
Antibody
Tiling Arrays
Epigenetic Mapping Arrays
Cytokine Arrays
Whole Proteome Arrays
Aptamer Arrays
Cell-Free Arrays
Protein Nanoarrays
Lab-on-a-Chip Technologies
The " Markets" report examines companies manufacturing equipment and supplies in the world. Companies covered include: Affymetrix, Agilent, Applied Biosystems/Invitrogen, Applied Microarrays, Arrayit, AutoGenomics, AyoxxA, BioCat, BioChain, BioForce, BioGenex, Biolog, Biomedical, bioMérieux, Biometrix, Bio-Rad, Cancer Genetics, Cepheid, Clontech, CombiMatrix, CYBRDI, DiagnoSwiss, Discerna, EMD Millipore, Eurogentec, Exiqon, Fluidigm, Gamida for Life Group, GE Healthcare, Grace Bio-Labs, Great Basin, Greiner Bio-One, Gyros AB, Healthcare IT, Illumina, Imgenex, Immucor, InDevR, Isu Abxis, LC Sciences, Lineagen, Luminex, Maine Manufacturing, Meso Scale Discovery, Microarrays, Microbionix, Mingyuan Medicare, MiraiBio, Molecular Devices, Monogram, Myriad Genetics, NextGen, One Lambda, OriGene, Orla Protein, Oxford Gene, Oxford Nanopore, PamGene BV, Partek, Pepscan, Perkin Elmer, Phalanx, PharmaSeq, Platypus, Protagen, ProteinOne, ProteoGenix, QIAGEN, R&D Systems, Radix BioSolutions, Randox, RayBiotech, Roche NimbleGen, Sequenom, Sigma-Aldrich, SmartBead, SomaLogic, SQI, SuperBioChips, Theranostic Health, Toray Industries, Trans Genic, US Biomax, Veredus, Zeptosens, Zeus Scientific and Zyagen.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: .
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit .
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 12.08.2013 - 17:45 Uhr
Sprache: Deutsch
News-ID 286840
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 246 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Global Microarray Market to Catapult to $7.4 Billion by 2018"
steht unter der journalistisch-redaktionellen Verantwortung von
TriMarkPublications.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
